The multidisciplinary nature of public health genetics in research and education

Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease

Volumn , Issue , 2009, Pages

  Austin, Melisa A ^a   Peyser, Patricia A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Education; Graduate programs; Michigan; Public health genetics; Washington

Indexed keywords

EID: 84940012427     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195128307.003.0005     Document Type: Chapter

References (59)

1. Collins FS, Patrinos A, Jordon E, Chakravarti A, Gesteland R, Walters L. New goals for the U.S. Human Genome Project: 1998-2003. Science 1998;282:682-689.
2. Omenn GS. Genetics and public health. Am J Public Health 1996;86:1701-1704.
3. Khoury MJ, and the Genetics Working Group. From gene to public health: the application of genetic technology in disease prevention. Am J Public Health 1996;86:1717-1722.
4. ten Kate L. Editorial. Community Genet 1998;1:1-2.
5. Metzger N, Zare RN. Interdisciplinary research: from belief to reality. Science 1999;283:642-643.
6. Ellsworth DL, Hallman DM, Boerwinkle E. Impact of the Human Genome Project on epidemiologic research. Epidemiol Rev 1997;19:3-13.
7. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York:Oxford University Press, 1993.
8. Hanis CL, Boerwinkle E, Chakraborty R, et al. A genome-wide search for human noninsulin- dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996;13:161-166.
9. Cox NJ, Frigge M, Nicolae DL, et al. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 1999;21:213-215.
10. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
11. Austin MA, Talmud PJ, Luong LA, et al. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet 1998;62:406-419.
12. Foxman B, Zhang L,Tallman P, et al. Transmission of uropathogens between sex partners. J Infect Dis 1997;175:989-992.
13. Khoury MJ, Risch N, Kelsey JL. Genetic epidemiology. Epidemiol Rev 1997;19:1-181.
14. Schulte PA, Perera P. Molecular epidemology: principles and practices. San Diego:Academic Press, 1993.
15. Khoury MJ. Human Genome Epidemiology (HuGE): translating advances in human genetics into population-based data for medicine and public health. Genet Med 1999;1:71-74.
16. Khoury MJ, Dorman JS. The Human Genome Epidemiology Network (HuGE Net). Am J Epidemiol 1998;148:1-3.
17. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
18. Jenks PJ. Microbial genome sequencing-beyond the double helix. BMJ 1998;317:1568-1571.
19. Haines JL, Pericak-Vance MA. Approaches to gene mapping in complex human diseases. New York: Wiley-Liss, 1998.
20. Ott J. Analysis of human genetic linkage. Baltimore: The Johns Hopkins University Press, 1999.
21. Hauser ER, Boehnke M. Genetic linkage analysis of complex genetic traits by using affected sibling pairs. Biometrics 1998;54:1238-1246.
22. Boehnke M, Langfeld CD. Genetic association mapping based on discordant sib pairs:the discordant-alleles test. Am J Hum Genet 1998;62:950-961.
23. Goldin LR, Bailey-Wilson JE, Borecki IB, et al. Genetic analysis workshop 10. Genet Epidemiol 1996;14:549-1142.
24. Kardia SLR, Nelson MR, Ferrell RE, Sing CF. New approaches for identifying multilocus genotypes influencing levels of quantitative risk factors. Am J Hum Genet 1997;61:1167.
25. Nickerson DA, Taylor SL, Weiss KM, et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet 1998;19:233-240.
26. Gelbart WM. Databases in genomic research. Science 1998;282:659-661.
27. Carmelli D, Swan GE, Robinette D, Fabstiz R. Genetic influence on smoking-a study of male twins. N Engl J Med 1992;327:829-833.
28. Edwards KL, Austin MA, Jarvik GP. Evidence for genetic influences on smoking in adult women twins. Clin Genet 1995;47:236-244.
29. Pianezza ML, Sellers EM, Tyndale RF. Nicotine metabolism defect reduces smoking. Nature 1998;393:750.
30. London SJ, Idle JR, Daly AK, Coetzee GA. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 1999;353:898-899.
31. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. JAMA 1997;277:1305-1307.
32. Vandenbroucke JP, Koster T, Briet E, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-1457.
33. Middeldorp S, Henkens CM, Koopman MM, et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998;128:15-20.
34. McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy-associated venous thromboembolism. Thromb Haemost 1997;78:1183-1188.
35. Vandenbroucke JP, van der Meer FJ, Helmerhorst FM, Rosendaal FR. Factor V Leiden: should we screen oral contraceptive users and pregnant women? BMJ 1996;313:1127-1130.
36. Drewnoski A, Rock C. The influence of genetic taste markers on food acceptance. Am J Clin Nutr 1995;62:506-511.
37. Lerman C, Hughes C, Trock BJ, et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999;281:1618-1622.
38. Ramsey SD. Economic implications of genetic screening for cancer susceptibility: the case of hereditary nonpolyposis colorectal cancer. First Annual Conference on Genetics and Public Health, Atlanta, GA, 1998.
39. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998;280:172-178.
40. McConnell LM, Koenig BA, Greely HT, Raffin TA, and the Working Group of the Stanford Program in Genomics, Ethics, and Society. Genetic testing and Alzheimer disease: has the time come? Nat Med 1998;4:757-759.
41. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG. Assessing genetic risks:implications for health and social policy. Washington, DC: National Academy Press, 1994.
42. Fitzpatrick JL, Hahn C, Costa T, Huggins MJ. The duty to recontact: attitudes of genetics service providers. Am J Hum Genet 1999;64:852-860.
43. Juengst ET. Groups as gatekeepers to genomic research: conceptually confusing, morally hazardous, and practically useless. Kennedy Inst Ethics J 1998;8:183-200.
44. Foster MW, Sharp RR, Freeman WL, Chino M, Bernsten D, Carter TH. The role of community review in evaluating risk of human genetic variation in research. Am J Hum Genet 1999;64:1719-1727.
45. National Commission for the Protection of Human Subjects of Biomedical and Behavior Research. The Belmont Report. Washington, DC: GPO, 8pp., 1979.
46. Reilly PR, Page DC. We're off to see the genome. Nat Genet 1998;20:15-17.
47. Clayton EW, Steinberg KK, Khoury MJ, et al. Informed consent for genetic research on stored tissue samples. JAMA 1995;274:1786-1792.
48. Greely HT. Genomics research and human subjects. Science 1998;282:625.
49. Botkin JR, McMahon WM, Smith KR, Nash JE. Privacy and confidentiality in the publication of pedigrees: a survey of investigators and biomedical journals. JAMA 1998;279:1808-1812.
50. Specter M. Decoding Iceland. The New Yorker, January 18, 1999, pp. 40-51.
51. Ziman J. Why must scientists become more ethically sensitive than they used to be? Science 1998;282:1813-1814.
52. Safer v. Estate of Pack. (291 N.J. Super. 619), 1996.
53. Miller PS. Genetic discrimination in the workplace. J Law Med Ethics 1998;26:189-197.
54. Nelkin D, Andrews L. Homo economicus: commercialization of body tissue in the age of biotechnology. Hastings Cent Rep September-October 1998:30-39.
55. Hanson MJ. Religious voices in biotechnology: the case of gene patenting. Hastings Cent Rep 1997;November-December:1-21.
56. Koenig BA, Greely HT, McConnell LM, Silverberg AB, Raffin TA, and members of the Breast Cancer Working Group of the Stanford Program in Genomics, Ethics, and Society. Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society. J Womens Health 1998;7:531-545.
57. Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR, on behalf of an international Huntingon disease collaborative group. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999;63:1293-1304.
58. Office of Genetics and Disease Prevention Home Page. .
59. Breslow L. From disease prevention to health promotion. JAMA 1999;281: 1030-1033.